Clinical Trials Browser

Enrolling by invitation × Interventional × Loperamide × Clear all

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma